Page last updated: 2024-08-25

talinolol and allopurinol

talinolol has been researched along with allopurinol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Boguschewski, KD; Brämer, U; Dobritz, H; Hitzeroth, T; Mann, D1

Trials

1 trial(s) available for talinolol and allopurinol

ArticleYear
[Long-term studies on the beta blocker talinolol (cordanum) with special reference to side effects].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1979, Apr-01, Volume: 34, Issue:7

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Allopurinol; Angina Pectoris; Arrhythmias, Cardiac; Double-Blind Method; Fatigue; Female; Headache; Humans; Hypertension; Male; Middle Aged; Phenylurea Compounds; Propanolamines; Sleep Initiation and Maintenance Disorders

1979

Other Studies

3 other study(ies) available for talinolol and allopurinol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010